Not available
Quote | Zosano Pharma Corporation (NASDAQ:ZSAN)
Last: | $0.5576 |
---|---|
Change Percent: | 7.23% |
Open: | $0.5188 |
Close: | $0.5576 |
High: | $0.635 |
Low: | $0.46 |
Volume: | 1,131,329 |
Last Trade Date Time: | 06/10/2022 04:54:17 pm |
News | Zosano Pharma Corporation (NASDAQ:ZSAN)
Gainers: Turning Point Therapeutics (TPTX) +117%. Energy Focus (EFOI) +40%. Galecto (GLTO) +25%. Adaptimmune (ADAP) +22%. Amylyx Pharmaceuticals (AMLX) +22%. AudioEye (AEYE) +20%. Sprague Resources LP (SRLP) +20%. Global Cord Blood (CO) +18%. GreenBox (GBOX) +17%. Kopin (KOPN) +15%. Losers: N...
Gainers: Immix Biopharma (IMMX) +37%. Bright Green (BGXX) +29%. Repare Therapeutics (RPTX) +29%. Yumanity Therapeutics (YMTX) +24%. PDS Biotechnology (PDSB) +15%. Losers: Zosano Pharma (ZSAN) -48%. Immunic (IMUX) -41%. Aeglea BioTherapeutics (AGLE) -40%...
Message Board Posts | Zosano Pharma Corporation (NASDAQ:ZSAN)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Zosano Pharma Corporation Company Name:
ZSAN Stock Symbol:
NASDAQ Market:
Zosano Pharma Corporation Website:
FREMONT, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on June 1, 2022 it filed a voluntary petition for relief under chapter 11 of title 11 (“Chapter 11”) of the United ...
FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022. All share and per share information included in these financial results a...